Ana Oaknin, Anna Tinker, Lucy Gilbert, Vanessa Samouëlian, Cara Mathews, et al.. Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer.
Future Oncology, Future Medicine, 2021, 17 (29), pp.3781-3785.
⟨10.2217/fon-2021-0598⟩.
⟨hal-03623657⟩